2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Glaucoma, Angle-Closure: new trials by email Literature Review of Glaucoma, Angle-Closure trials Research Report on Glaucoma, Angle-Closure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG) QPI-1007 Injection, (including placebo) - Glaucoma, Angle-closure, Primary, Acute | Phase 2 | Completed | Quark Pharmaceuticals | 46 | 2013-12-01 | 2017-04-07 |
| Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery? Triesence, balanced salt solution BSS - Glaucoma | Phase 2 / Phase 3 | Completed | Wills Eye | 77 | 2009-02-01 | 2018-07-10 |
Glaucoma (2) · Exfoliation Syndrome (1) · Glaucoma, Neovascular (1) · Glaucoma, Open-Angle (1)
Eye Diseases (2) · Ocular Hypertension (2) · Iris Diseases (1) · Uveal Diseases (1)
Hanks Balanced Salt Solution (1) · Triamcinolone (1)
Quark Pharmaceuticals (1) · Wills Eye (1)
United States (2) · Singapore (1) · Vietnam (1)
Avner Ingerman, M.D., MSc. (1) · Marlene R Moster, MD (1)